Initial Management of Carotid Atherosclerosis

Medical Therapy

• The American College of Cardiology recommends antiplatelet therapy, such as aspirin 75-325 mg daily or clopidogrel 75 mg daily, for all patients with carotid atherosclerosis to prevent myocardial infarction and other ischemic events 1, 2, 3
• Aspirin 75-325 mg daily is recommended for all patients with carotid atherosclerosis to prevent myocardial infarction and other ischemic events, according to the American College of Cardiology 1, 2, 3
• Clopidogrel 75 mg daily is an acceptable alternative to aspirin for patients with carotid atherosclerosis, as stated by the American Heart Association 4, 3
• For patients with recent TIA or ischemic stroke associated with carotid disease, the American Heart Association recommends three options: aspirin alone (81-325 mg daily), aspirin plus extended-release dipyridamole (25/200 mg twice daily), or clopidogrel 75 mg daily 4, 3
• Statin therapy is mandatory for all patients with carotid atherosclerosis, regardless of baseline lipid levels, according to the American College of Cardiology 5
• Antihypertensive medication must be administered to achieve target blood pressure levels, as recommended by the American College of Cardiology 6, 5

Diagnostic Evaluation

• Noninvasive imaging with carotid duplex ultrasound is the first-line diagnostic modality for assessing degree of stenosis, according to the American Heart Association 3, 7
• CTA or MRA should be obtained when ultrasound findings are inconclusive or when detailed anatomic information is needed for revascularization planning, as stated by the American College of Cardiology 1, 2, 3

Surveillance Protocol

• Initial post-diagnosis imaging at 1 month to establish baseline, as recommended by the American College of Cardiology 5
• Follow-up imaging at 6 months to assess stability and exclude new or contralateral lesions, according to the American College of Cardiology 6, 5
• Annual surveillance thereafter to monitor for progression, as recommended by the American College of Cardiology 6, 5

Special Considerations

• Diabetes should be optimized as it represents a risk factor for restenosis and disease progression, according to the American College of Cardiology 5
• Female gender, chronic kidney disease, dyslipidemia, and smoking increase restenosis risk and may warrant more frequent surveillance, as stated by the American College of Cardiology 5
• Reoperative intervention is reasonable when duplex ultrasound and confirmatory imaging identify rapidly progressive stenosis threatening complete occlusion, according to the American College of Cardiology 6, 5

Common Pitfalls to Avoid

• Do not withhold statin therapy based on "normal" lipid levels—statins are indicated for plaque stabilization independent of lipid values, as recommended by the American College of Cardiology 5
• Do not perform revascularization in asymptomatic patients with <70% stenosis that has remained stable over time, according to the American College of Cardiology 1, 6